News

News Feed

April 22nd

Dear Aptos Partners, dear Colleagues, The unfolding coronavirus (COVID-19) crisis has significantly affected all industries. For safety reasons many countries declared state of emergency, and some of them even imposed a national quarantine, restricting the movement of the population except for necessity, work, and health circumstances. As numerous companies all around the world, Aptos also made remote working mandatory for all workers globally – now all of us are working from home and each of us are still on direct contact with our partners. You can still reach them out on their emails or contact our Executive office at hello@aptos.ge. We do not recommend calling our offices by telephone at this time. To keep our close contacts with doctors Aptos initiated online trainings. Starting from March 30th we began a cycle of free exclusive webinars hosted by our co-inventors and experts on Aptos Threads and Methods. Each seminar has a new, interesting topic and is announced on our official social media pages several days before we go live. So, don’t forget to follow us on Instagram and Facebook. We would like to thank you all for your cooperation. We wish you all health!

see more
April 22nd

EBRD Georgia supports innovation in the Aesthetic Medicine industry by signing the third Blue Ribbon project with Aptos Aptos, has become 2020 Blue Ribbon champion. EBRD First Vice President Jurgen Rigternik signed the agreement along with George Sulamanidze, General Director of Aptos, during his recent trip to Tbilisi on March 6. Georgia ASB team started working with Aptos in 2017, through advisory services to help the company improve its management effectiveness by developing appropriate business model, expanding product portfolio and implementing a franchise system for Aptos products and services. The successful implementation of the first stage of the advisory in 2018 led to the company signing up for the International Advisory project to improve the company’s strategic approach on regional and global level, and updating the organisational structure including the HR operations, as well as develop long-term sales plan while continuing to improve business processes and distribution management. Aptos is a family-owned business found by Mr. Marlen Sulamanidze, a famous Georgian plastic surgeon, and his two sons, also plastic surgeons Dr. George Sulamanidze who acts as the CEO of the company, and Dr. Konstantin Sulamanidze. The company is the leader in the beauty and aesthetics industry and is a manufacturer of a barbed thread and other unique materials used in plastic surgery and cosmetology. Aptos’s products and methods of treatment gained world recognition and are successfully used by the aesthetic physicians in 71 countries worldwide. The company sells its products directly and through distributors globally. The family ‘trio’ received many prestigious international awards and 18 patents for invention and innovation. Aptos is an international brand originated in Georgia, with production facilities based in Georgia, Russia, and Germany. The company's clinics operate in Russia, Georgia and Czech Republic. It now has an ambition to expand further in Europe, as well as in the US, Brazil and China. This is a true success story. EBRD is proud to support the development of the local brand set to become a global player. Following the successful implementation of the Advisory project, Georgia ASB team referred the company to the EBRD bankers which resulted in them signing the loan for Aptos via the Risk Sharing Facility with TBC Bank in and in December 2019. The loan is financing capital expenditures related to the construction of new energy efficient production facilities. Mr. George Sulamanidze emphasised during the signing ceremonial that the EBRD Advisory initiative brought to them wealth of knowledge in terms of management and structure and helped them overcome weaknesses. It has also helped the company identify its strengths and define its market position which allowed it to mitigate future risks better. When they thought it could not get better the EBRD approached the company to support the project not just with the know-how but also with financing. At this stage, he understood that his family managed to build a truly great brand and business that will never stop to innovate, expand, and strive to make humans beautiful, at least, from the ‘outside’.

see more
April 22nd

> Click on 'learn more' to read the article Comparison of the Influence of New Generation Threads P(LA/ CL) HA And P(LA/CL) on Convalescence and Clinical Effects in Patients Undergoing Minimally Invasive Anti-Aging Treatments Abstract Early signs of aging of facial skin results from elastic tissue and collagen degradation, causing fine-to-deep wrinkles formation. Various modifications of the techniques have been introduced to fight against aging. In recent years, minimally invasive procedures, in particular tread lifting gained more and more interest both among patient and the practitioners. Nowadays, wide range of threads with different compositions and configurations are presented on the markets. This pilot study was done to evaluate subjective assessments of P (LA/CL) (HA) and P (LA/CL) threads and compare their impact on convalescence and clinical outcome in patients undergoing various anti-aging treatments. Patients received appropriate non-invasive aesthetic treatment combined with P(LA/CL) HA and P(LA/CL) thread implantation on the opposing side of their face. The patients’ subjective impressions, given as a numerical value based on the Global Aesthetic Improvement Scale, were collected on the day of the procedure and at 3, 6, and 9 weeks after the procedure. The study involved 9 women, aged 40 to 63, and investigated the assessment of the convalescence period, changes in the appearance and skin quality, as well as lifting and volumetric effects. The results revealed significant acceptance of the convalescence period, greater satisfaction with skin quality improvement, and similar lifting effects and volumetric changes. Keywords: Face lifting; Threads; Hyaluronic acid; Skin texture Authors: Dr. Bo?ena Jendrysik, Dr. Albina Kajaia, Dr. George Sulamanidze.

see more